Business
Press Release Aug 01 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 01, 2023, titled "Aurobindo Pharma receives USFDA Approval for Saxagliptin Tablets, 2.5 mg and 5 mg.".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 01, 2023, titled \"Aurobindo Pharma receives USFDA Approval for Saxagliptin Tablets, 2.5 mg and 5 mg.\". View Attachment","length":350,"tagName":"div"}]